A share price of Aquestive Therapeutics Inc [AQST] is currently trading at $5.91, up 1.55%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AQST shares have gain 3.87% over the last week, with a monthly amount drifted -21.09%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on December 17, 2024, and set its price target to $17. On May 10, 2024, Leerink Partners initiated with an Outperform rating and assigned a price target of $8 on the stock. Piper Sandler started tracking the stock assigning an Overweight rating and suggested a price target of $10 on April 11, 2024. Raymond James initiated its recommendation with an Outperform and recommended $7 as its price target on March 28, 2024. In a note dated April 22, 2019, H.C. Wainwright initiated a Buy rating.
Aquestive Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $2.12 and $7.55. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. Aquestive Therapeutics Inc [NASDAQ: AQST] shares were valued at $5.91 at the most recent close of the market. An investor can expect a potential return of 103.05% based on the average AQST price forecast.
Analyzing the AQST fundamentals
Trailing Twelve Months sales for Aquestive Therapeutics Inc [NASDAQ:AQST] were 43.40M which represents -5.43% decline. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at -1.19%, Pretax Profit Margin comes in at -1.47%, and Net Profit Margin reading is -1.47%. To continue investigating profitability, this company’s Return on Assets is posted at -0.69, Equity is 1.09 and Total Capital is -0.75. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-1.74.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.74 points at the first support level, and at 5.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.01, and for the 2nd resistance point, it is at 6.12.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Aquestive Therapeutics Inc [NASDAQ:AQST] is 5.93. In addition, the Quick Ratio stands at 5.62 and the Cash Ratio stands at 2.61. Considering the valuation of this stock, the price to sales ratio is 16.61.
Transactions by insiders
Recent insider trading involved Carl N. Kraus, Affiliate, that happened on Nov 17 ’25 when 53100.0 shares were purchased. Chief Operating Officer, Jung Cassie completed a deal on Oct 15 ’25 to sell 67575.0 shares. Meanwhile, Chief Medical Officer Kraus Carl N sold 20272.0 shares on Oct 15 ’25.
